The pathogenesis of neuroinvasion in Creutzfeldt-Jakob disease and other transmissible spongiform encephalopathies following the peripheral uptake of a disease agent is still not fully understood. The possibility of neuroinvasion either being established or being accelerated by an insult to the brain has not previously been tested. The experiment described herein was designed to examine this possibility by wounding the brain following an intraperitoneal challenge with a mouse-adapted strain of human transmissible spongiform encephalopathy, Fukuoka-1 strain. The results showed that brain injury introduced in any period before the appearance of cerebral abnormal prion protein deposition modified neither the clinical features, including the incubation period, nor the histopathology of the mice. Our findings suggest that neurovirulence of the agent may not be sufficiently promoted by brain injury.
Anon1997; Creutzfeldt–Jakob disease associated with cadaveric dura mater grafts – Japan, January 1979–May 1996. Morbidity and Mortality Weekly Report 46:1066–1069
BeekesM.,
McBrideP. A.,
BaldaufE.1998; Cerebral targeting indicates vagal spread of infection in hamsters fed with scrapie. Journal of General Virology 79:601–607
BrownP.,
RohwerR. G.,
DunstanB. C.,
MacAuleyC.,
GajdusekD. C.,
DrohanW. N.1998; The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy. Transfusion 38:810–816
CasacciaP.,
LadoganaA.,
XiY. G.,
PocchiariM.1989; Levels of infectivity in the blood throughout the incubation period of hamsters peripherally injected with scrapie. Archives of Virology 108:145–149
ChungY. L.,
WilliamsA.,
BeechJ. S.,
WilliamsS. C.,
BellJ. D.,
CoxJ.,
HopeJ.1995; MRI assessment of the blood-brain barrier in a hamster model of scrapie. Neurodegeneration 4:203–207
FraserH.1976; The pathology of natural and experimental scrapie. In Slow Virus Diseases of Animals and Man pp 267–305 Edited by
KimberlinR. H.
New York: North-Holland;
FraserH.,
BruceM. E.,
DaviesD.,
FarquharC. F.,
McBrideP. A.1992; The lymphoreticular system in the pathogenesis of scrapie. In Prion Diseases of Humans and Animals pp 308–317 Edited by
CollingeJ.,
PowellJ.,
AndertonB.
Chichester: Ellis Horwood;
GajdusekD. C.,
GibbsC. J.Jr,
CollinsG.,
TraubR.1976; Survival of Creutzfeldt–Jakob disease virus in formalin-fixed tissue. New England Journal of Medicine 294:553
GibbsC. J.Jr,
GajdusekD. C.,
MastersC. L.1978; Considerations of transmissible subacute and chronic infections, with a summary of the clinical and virological characteristics of kuru, Creutzfeldt–Jakob disease and scrapie. In Senile Dementia A Biomedical Approach pp 115–130 Edited by
NandyK.
New York: Elsevier/North-Holland Biomedical Press;
KimberlinR. H.,
WalkerC. A.1979; Pathogenesis of mouse scrapie: dynamics of agent replication in spleen, spinal cord and brain after infection by different routes. Journal of Comparative Pathology 89:551–562
KimberlinR. H.,
WalkerC. A.1986; Pathogenesis of scrapie (strain 263K) in hamsters infected intracerebrally, intraperitoneally or intraocularly. Journal of General Virology 67:255–263
KitamotoT.,
MuramotoT.,
HilbichC.,
BeyreutherK.,
TateishiJ.1991a; N-terminal sequence of prion protein is also integrated into kuru plaques in patients with Gerstmann–Sträussler syndrome. Brain Research 545:319–321
KitamotoT.,
MuramotoT.,
MohriS.,
Doh-uraK.,
TateishiJ.1991b; Abnormal isoform of prion protein accumulates in follicular dendritic cells in mice with Creutzfeldt–Jakob disease. Journal of Virology 65:6292–6295
KitamotoT.,
ShinR. W.,
Doh-uraK.,
TomokaneN.,
MiyazonoM.,
MuramotoT.,
TateishiJ.1992; Abnormal isoform of prion proteins accumulates in the synaptic structures of the central nervous system in patients with Creutzfeldt–Jakob disease. American Journal of Pathology 140:1285–1294
KleinM. A.,
FriggR.,
FlechsigE.,
RaeberA. J.,
KalinkeU.,
BluethmannH.,
BootzF.,
SuterM.,
ZinkernagelR. M.,
AguzziA.1997; A crucial role for B cells in neuroinvasive scrapie. Nature 390:687–690
KurodaY.,
GibbsC. J.Jr,
AmyxH. L.,
GajdusekD. C.1983; Creutzfeldt–Jakob disease in mice: persistent viremia and preferential replication of virus in low-density lymphocytes. Infection and Immunity 41:154–161
LasmézasC.-I.,
DeslysJ.-P.,
DemaimayR.,
AdjouK. T.,
HauwJ. J.,
DormontD.1996; Strain specific and common pathogenic events in murine models of scrapie and bovine spongiform encephalopathy. Journal of General Virology 77:1601–1609
LynchW. P.,
RobertsonS. J.,
PortisJ. L.1995; Induction of focal spongiform neurodegeneration in developmentally resistant mice by implantation of murine retrovirus-infected microglia. Journal of Virology 69:1408–1419
MenacheD.,
O’MalleyJ. P.1996; Creutzfeldt–Jakob: current US policy to further reduce the possible risk of transmission by transfusion. Biologicals 24:277–283
Morganti-KossmanM. C.,
LenzlingerP. M.,
HansV.,
StahelP.,
CsukaE.,
AmmannE.,
StockerR.,
TrentzO.,
KossmannT.1997; Production of cytokines following brain injury: beneficial and deleterious for the damaged tissue. Molecular Psychiatry 2:133–136
RickettsM. N.,
CashmanN. R.,
StrattonE. E.,
EisaadanyS.1997; Is Creutzfeldt–Jakob disease transmitted in blood?. Emerging Infectious Diseases 3:155–163
SatohJ.,
KuroharaK.,
YukitakeM.,
KurodaY.1998; Constitutive and cytokine-inducible expression of prion protein gene in human neural cell lines. Journal of Neuropathology and Experimental Neurology 57:131–139
SchmittT. L.,
SteinerE.,
KlingerP.,
SztankayA.,
Grubeck-LoebensteinB.1996; The production of an amyloidogenic metabolite of the Alzheimer amyloid beta precursor protein (APP) in thyroid cells is stimulated by interleukin 1 beta, but inhibited by interferon gamma. Journal of Clinical Endocrinology and Metabolism 81:1666–1669
TateishiJ.,
OhtaM.,
KogaM.,
SatoY.,
KuroiwaY.1980a; Transmission of chronic spongiform encephalopathy with kuru plaques and leukomalacia to small rodents. Annals of Neurology 5:581–584
TateishiJ.,
SatoY.,
KogaM.,
DoiH.,
OhtaM.1980b; Experimental transmission of human subacute spongiform encephalopathy to small rodents. I. Clinical and histological observations. Acta Neuropathologica 51:127–134
VorbrodtA. W.,
DobrogowskaD. H.,
TarnawskiM.,
MeekerH. C.,
CarpR. I.1997; Immunocytochemical evaluation of blood-brain barrier to endogenous albumin in scrapie-infected mice. Acta Neuropathologica 93:341–348
WilliamsA.,
Van DamA. M.,
RitchieD.,
EikelenboomP.,
FraserH.1997; Immunocytochemical appearance of cytokines, prostaglandin E2 and lipocortin-1 in the CNS during the incubation period of murine scrapie correlates with progressive PrP accumulations. Brain Research 754:171–180
WisniewskiH. M.,
LossinskyA. S.,
MoretzR. C.,
VorbrodtA. W.,
LassmannH.,
CarpR. I.1983; Increased blood–brain barrier permeability in scrapie-infected mice. Journal of Neuropathology and Experimental Neurology 42:615–626
Wyss-CorayT.,
MasliahE.,
MalloryM.,
McConloguL.,
Johnson-WoodK.,
LinC.,
MuckeL.1997; Amyloidogenic role of cytokine TGF-beta1 in transgenic mice and in Alzheimer′s disease. Nature 389:603–606